Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:300231rdf:typepubmed:Citationlld:pubmed
pubmed-article:300231lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C0521339lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C1148673lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C0444706lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C2826293lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C0449851lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C0302891lld:lifeskim
pubmed-article:300231lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:300231pubmed:issue1lld:pubmed
pubmed-article:300231pubmed:dateCreated1977-4-15lld:pubmed
pubmed-article:300231pubmed:abstractTextThe clinical significance of antinative DNA antibodies as measured by the Farr test was investigated in 10 patients with the articular features of rheumatoid arthritis. 5 of these patients also satisfied criteria for a diagnosis of systemic lupus erythematosus (SLE) and might be classified as rheumatoid/lupus overlap syndromes or as rheumatoids with systemic complications. None had evidence of renal disease and 3 of the 5 had Sjgøren's syndrome. The sixth patient had aggressive peripheral arthritis, alopecia, and Sjøgren's syndrome and developed anti-DNA antibodies after treatment with penicillamine. All of the 4 rheumatoid patients with no clinical features typical of SLE had some special disease feature. The first had subclinical liver disease and the other 3 had Sjøgren's syndrome in addition to localized vasculitic skin ulceration (2) and pulmonary fibrosis (1).lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:languageenglld:pubmed
pubmed-article:300231pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:citationSubsetIMlld:pubmed
pubmed-article:300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:300231pubmed:statusMEDLINElld:pubmed
pubmed-article:300231pubmed:monthFeblld:pubmed
pubmed-article:300231pubmed:issn0003-4967lld:pubmed
pubmed-article:300231pubmed:authorpubmed-author:DickW CWClld:pubmed
pubmed-article:300231pubmed:authorpubmed-author:GrennanD MDMlld:pubmed
pubmed-article:300231pubmed:authorpubmed-author:SloaneDDlld:pubmed
pubmed-article:300231pubmed:authorpubmed-author:BehanAAlld:pubmed
pubmed-article:300231pubmed:issnTypePrintlld:pubmed
pubmed-article:300231pubmed:volume36lld:pubmed
pubmed-article:300231pubmed:ownerNLMlld:pubmed
pubmed-article:300231pubmed:authorsCompleteYlld:pubmed
pubmed-article:300231pubmed:pagination30-3lld:pubmed
pubmed-article:300231pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-H...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-A...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-L...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-A...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-S...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-F...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-D...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-M...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-A...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-M...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-A...lld:pubmed
pubmed-article:300231pubmed:meshHeadingpubmed-meshheading:300231-B...lld:pubmed
pubmed-article:300231pubmed:year1977lld:pubmed
pubmed-article:300231pubmed:articleTitleClinical significance of antibodies to native DNA as measured by a DNA binding technique in patients with articular features of rheumatoid arthritis.lld:pubmed
pubmed-article:300231pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:300231lld:pubmed